Related Experiment Video
Updated: Aug 23, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
CTGF as a multifunctional molecule for cartilage and a potential drug for osteoarthritis
Zihuan Yang1, Weishi Li1,2, Chunli Song1,3
1Department of Orthopaedics, Peking University Third Hospital, Beijing, China.
Abstract:
CTGF is a multifunctional protein and plays different roles in different cells and under different conditions. Pamrevlumab, a monoclonal antibody against CTGF, is an FDA approved drug for idiopathic pulmonary fibrosis (IPF) and Duchenne muscular dystrophy (DMD). Recent studies have shown that CTGF antibodies may potentially serve as a new drug for osteoarthritis (OA). Expression of CTGF is significantly higher in OA joints than in healthy counterparts. Increasing attention has been attracted due to its interesting roles in joint homeostasis. Joint homeostasis relies on normal cellular functions and cell-cell interactions. CTGF is essential for physiological activities of chondrocytes. Abnormal CTGF expression may cause cartilage degeneration. In this review, the physiological functions of CTGF in chondrocytes and related mechanisms are summarized. Changes in the related signaling pathways due to abnormal CTGF are discussed, which are contributing factors to inflammation, cartilage degeneration and synovial fibrosis in OA. The possibility of CTGF as a potential therapeutic target for OA treatment are reviewed.
Insights
Connective tissue growth factor (CTGF) plays a key role in joint homeostasis. Targeting CTGF with antibodies, like pamrevlumab, shows promise for treating osteoarthritis by preventing cartilage degeneration and fibrosis.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Connective tissue growth factor (CTGF) is a multifunctional protein involved in various cellular processes.
- Elevated CTGF expression is observed in osteoarthritis (OA) joints compared to healthy joints.
- CTGF is crucial for chondrocyte function and maintaining joint homeostasis.
Purpose of the Study:
- To review the physiological functions of CTGF in chondrocytes.
- To discuss the mechanisms underlying abnormal CTGF expression in OA.
- To evaluate CTGF as a potential therapeutic target for osteoarthritis.
Main Methods:
- Literature review of studies on CTGF in chondrocytes and OA.
- Analysis of signaling pathways affected by abnormal CTGF expression.
- Examination of existing data on CTGF-targeting therapies.
Main Results:
- Abnormal CTGF expression contributes to cartilage degeneration, inflammation, and synovial fibrosis in OA.
- CTGF is essential for normal chondrocyte function and joint homeostasis.
- CTGF antibodies, such as pamrevlumab, are being investigated for OA treatment.
Conclusions:
- CTGF plays a significant role in the pathogenesis of osteoarthritis.
- Modulating CTGF activity presents a potential therapeutic strategy for OA.
- Further research into CTGF-targeting therapies could lead to novel treatments for OA.
Related Concept Videos
TGF - β Signaling Pathway
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Growth of Cartilage and Bone Tissue
Osteoclasts in Bone Remodeling
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

